Bioqual Inc BIOQ:OTCPK

RT Quote | Exchange | USD
Last | 12/30/22 EST
81.80UNCH (UNCH)
52 week range
57.00 - 96.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close81.80
  • 52 Week High96.00
  • 52 Week High Date09/07/22
  • 52 Week Low57.00
  • 52 Week Low Date06/17/22

Key Stats

  • Market Cap73.164M
  • Shares Out894,420.03
  • 10 Day Average Volume-
  • Dividend1.00
  • Dividend Yield1.22%
  • Beta-0.30
  • YTD % Change1.737268302591932e-14

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close81.80
  • 52 Week High96.00
  • 52 Week High Date09/07/22
  • 52 Week Low57.00
  • 52 Week Low Date06/17/22
  • Market Cap73.164M
  • Shares Out894,420.03
  • 10 Day Average Volume-
  • Dividend1.00
  • Dividend Yield1.22%
  • Beta-0.30
  • YTD % Change1.737268302591932e-14

RATIOS/PROFITABILITY

  • EPS (TTM)5.89
  • P/E (TTM)13.89
  • Fwd P/E (NTM)-
  • EBITDA (TTM)8.318M
  • ROE (TTM)14.24%
  • Revenue (TTM)66.488M
  • Gross Margin (TTM)20.19%
  • Net Margin (TTM)7.92%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date10/05/2022
  • Div Amount1.00
  • Split Date-
  • Split Factor-

Latest On Bioqual Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Bioqual, Inc. is engaged in performing contract research services, which is primarily focused on animal models of human diseases, including acquired immune deficiency syndrome (AIDS), influenza, Respiratory Syncytial Virus (RSV) infection, Coronavirus infections (including COVID-19), Flavivirus infections (including Zika and Dengue), malaria, hepatitis, cancer, and other emerging infectious diseases. The Company also performs in vitro contract research services. It is...
Mark Lewis Ph.D.
Chairman of the Board, President, Chief Executive Officer
Charles Kirk Jr.
Chief Financial Officer
Chander Sarma
Vice President - Facility Operations, Director - Information Technology
Address
9600 Medical Center Drive, Suite 101
Rockville, MD
20850-3336
United States